Hightide and Axcella report positive NASH data, while Enanta stumbles in PBC May 7, 2020 By Lee Landenberger No Comments Two companies, Hightide Therapeutics Inc. and Axcella Health Inc., posted positive data from recent liver disease studies while Enanta Pharmaceuticals Inc. missed its phase II liver study’s primary endpoint.Read More